SCHEMBL13636209

SCHEMBL13636209

O=C(Cc1ccc(-c2ccccc2)c(F)c1)N1CCN(CC2CC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 3/20 0.52
HTT P42858 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CDK2 P24941 1/20 0.47
CACNA2D1 P54289 2/20 0.47
CACNA1B Q00975 2/20 0.47
CACNB1 Q02641 2/20 0.47
HSD11B1 P28845 1/20 0.44
CACNA1C Q13936 1/20 0.44
LMNA P02545 3/20 0.43
PARP1 P09874 2/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
MAPT P10636 1/20 0.43
ROCK1 Q13464 2/20 0.42
USP2 O75604 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4390864 0.99 ALDH1A1 (0.51) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL13636252 0.77 POLB (0.57) ALDH1A1KDM4EHTTMEN1KMT2A
Hydrochloric Acid SCHEMBL4379415 0.76 POLB (0.56) ALDH1A1KDM4EHTTMEN1KMT2A
Desmethylflurbiprofen SCHEMBL538938 0.72 PTGS1 (0.56) KDM4EHTTMEN1KMT2ACDK2
Desmethylflurbiprofen SCHEMBL239447 0.71 PTGS1 (0.55) KDM4EHTTMEN1KMT2ACDK2
SCHEMBL7562017 0.70 PTGS1 (0.51) MEN1KMT2ACDK2LMNAHPGD
SCHEMBL5366470 0.69 TACR3 (0.71) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL3042198 0.69 S1PR5 (0.65)
SCHEMBL9342620 0.68 CDK2 (0.46) MEN1KMT2ACDK2LMNAHPGD
SCHEMBL13096729 0.67 CDK2 (0.53) ALDH1A1HTTMEN1KMT2ACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 ALDH1A1 1907/4885KDM4E 1567/4885HTT 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.